Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Treatment Options and Continuity of Care in MAFLD
Author(s): Carmen Lara-Romero , Manuel Romero-Gómez Added: 10 months ago

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
ESC 24: The POPular PAUSE TAVI Trial
Author(s): Dirk-Jan van Ginkel Added: 8 months ago
ESC Congress 2024 — No benefit of continuing oral anticoagulation during TAVI procedure.Investigator, Dr Dirk-Jan van Ginkel (St Antonius Hospital, NL) joins us to discuss the result of the POPular PAUSE TAVI trial (NCT04437303; St Antonius Hospital). Presented for the first time at ESC 2024, this multicenter, randomized, open-label clinical trial compared the safety and efficacy of continuous… View more

Anticoagulation

Prevention & Chronic Conditions
Part 2 - Medical Options for Advanced HFpEF/HFmrEF Patients
Author(s): Biykem Bozkurt , Muthiah Vaduganathan , Start date: Sep 11, 2024
Join us for an unparalleled educational journey dedicated to tackling the complexities of managing HFpEF and HFmrEF patients. This CME-accredited live roundtable is chaired by Dr Biykem Bozkurt (Baylor College of Medicine, US) and features insights from renowned experts Prof Pardeep Jhund (University of Glasgow, UK) and Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical… View more

Heart Failure
Author(s): Apisara Lohachatinante , Nuttanun Kittikunkanyakit , Sayamon Sukkha , et al Added: 9 months ago

Anticoagulation
Research Area(s) / Expertise: Job title: Professor of Medicine in the Division of Nephrology
Dr Navdeep Tangri is a Professor of Medicine in the Division of Nephrology at University of Manitoba, Winnipeg, CA.Dr Tangri's research programme is focused on the clinical management of patients with advanced chronic kidney disease. He developed the kidney failure risk equation (KFRE) to predict the need for dialysis in patients with chronic kidney disease. View more
The 7th Global NAFLD/MASLD Congress
Start date: Jun 24, 2024 End date: Jun 25, 2024
The conference is in production. If you would like to speak at this meeting contactlauren@globalengage.co.uk. NAFLD/MASLD continues to be a huge unmet clinical need globally, and although no therapy has received regulatory approval, there continues to be research advancing ourunderstanding of the disease’s mechanisms. Developments innon-invasivediagnostic biomarkerscontinue to offer the hope… View more

Cardiovascular Renal Metabolic
ESC 24 Hot Line Discussion: The AβYSS Trial
Author(s): Harriette Van Spall , Prof. Johanne Silvain Added: 8 months ago
ESC Congress 2024 — The interruption of beta blocker treatment was not non-inferior to a strategy of βB continuation.Host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) sits down with investigator, Prof Johanne Silvain(Pitié-Salpêtrière University Hospital, Paris, FR) to discuss key results from the AβYSS trial (NCT03498066; Assistance Publique - Hôpitaux de Paris).The ABYSS trial… View more

MI/ACS
Jonathan Byrne
Research Area(s) / Expertise:

Hypertension

 Job title: PhD, MB, ChB
Dr Byrne completed his undergraduate medical training in Bristol and then continued general professional medical training in the South-East of England and London. He then undertook a PhD in the academic department of Cardiology at King’s College Hospital examining molecular mechanisms underlying left ventricular hypertrophy. Following completion he undertook his specialist training in… View more
Job title: Interventional Cardiologist
Job title: Interventional Cardiologist
Dr Joanna J Wykrzykowska obtained her Doctor of Medicine degree from Harvard Medical School and Massachusetts Institute of Technology, Boston MA in 2002. She completed her internal medicine residency at the Massachusetts General Hospital and her Cardiology Fellowship at Beth Israel Deaconess Medical Center (both Harvard teaching hospitals). She continued and completed her Interventional… View more